KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Intangibles (2018 - 2025)

Historic Intangibles for LifeMD (LFMD) over the last 8 years, with Q3 2025 value amounting to $15.2 million.

  • LifeMD's Intangibles rose 1259.26% to $15.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.2 million, marking a year-over-year increase of 1259.26%. This contributed to the annual value of $13.8 million for FY2024, which is 1708.9% up from last year.
  • Per LifeMD's latest filing, its Intangibles stood at $15.2 million for Q3 2025, which was up 1259.26% from $14.8 million recorded in Q2 2025.
  • LifeMD's Intangibles' 5-year high stood at $15.2 million during Q3 2025, with a 5-year trough of $400392.0 in Q1 2021.
  • Moreover, its 5-year median value for Intangibles was $11.3 million (2023), whereas its average is $9.9 million.
  • In the last 5 years, LifeMD's Intangibles crashed by 6682.31% in 2021 and then soared by 336175.82% in 2022.
  • LifeMD's Intangibles (Quarter) stood at $3.0 million in 2021, then skyrocketed by 195.09% to $8.8 million in 2022, then skyrocketed by 33.48% to $11.8 million in 2023, then rose by 17.09% to $13.8 million in 2024, then grew by 10.01% to $15.2 million in 2025.
  • Its Intangibles stands at $15.2 million for Q3 2025, versus $14.8 million for Q2 2025 and $14.3 million for Q1 2025.